Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Not Confirmed
Not Confirmed
27 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Webinar
Not Confirmed
27 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
06 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nasus-pharma-announces-ground-breaking-five-years-stability-of-its-fmxin002-nasal-epinephrine-powder-for-severe-allergy-and-anaphylaxis-302215369.html
05 Dec 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nasus-pharma-announces-positive-clinical-results-of-recent-phase-2-study-with-fmxin002-intranasal-epinephrine-302005774.html
08 Aug 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nasus-pharma-announces-publication-of-its-positive-clinical-results-with-fmxin002-intranasal-powder-epinephrine-spray-in-the-journal-of-allergy-and-clinical-immunology-in-practice-301895373.html
24 Nov 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/nasus-pharma-announces-clinical-data-demonstrating-efficacy-of-taffix--intranasal-antiviral-protection-against-common-cold-and-upper-respiratory-infection-301431485.html
17 Aug 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/taffix-r-recupera-la-aprobacion-de-comercializacion-en-espana-876429672.html
16 Aug 2021
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/taffix-regains-marketing-approval-in-spain-301355680.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?